Preclinical Characterisation of JNJ-54257099 – A Potent Uridine-Based Nucleotide Polymerase Inhibitor in Phase I Clinical Development for the Treatment of Chronic Hepatitis C
Tambuyzer, L, Vijgen, L, Jonckers, T.H, Lachau-Durand, S, Snoeys, J, Leclercq, L, Berke, J.M, Deval, J, Van Remoortere, P, Simmen, K, De Meyer, S, Raboisson, P
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
759 COMBINATION OF TMC435 WITH TWO NOVEL NS5B INHIBITORS INCREASES ANTI HCV ACTIVITY AND RESULTS IN A HIGHER GENETIC BARRIER IN VITRO
Lenz, O, Berke, J.M, de Kock, H, van Remoortere, P, Nyanguile, O, Vendeville, S, Jonckers, T, Raboisson, P, Simmen, K, Fanning, G, Lin, T.-I
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article
THU-261 - Preclinical Characterisation of JNJ-54257099 – A Potent Uridine-Based Nucleotide Polymerase Inhibitor in Phase I Clinical Development for the Treatment of Chronic Hepatitis C
Tambuyzer, L., Vijgen, L., Jonckers, T.H., Lachau-Durand, S., Snoeys, J., Leclercq, L., Berke, J.M., Deval, J., Van Remoortere, P., Simmen, K., De Meyer, S., Raboisson, P.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article